Le rapport « Place des vaccins bivalents contre la Covid-19 Comirnaty Original/Omicron BA.1 et Comirnaty Original/Omicron BA.4-BA.5 », ci-joint, est adopté
Voir aussi
Recommandation vaccinale
20/09/2022
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
HYYrg1XweK5nMezz
